ABEO (Abeona Therapeutics Inc.) הכנסות חזויות של החברה

The projected sales volume reflects future revenue trends, where the current metric is 0.04. Growth is driven by the global rollout of unique, high-margin gene therapies. The effective management of Abeona Therapeutics (ABEO) is successfully defending patents and engaging with the FDA. However, ultimate success depends on the final approval of the skin pathology therapy and the control of production timelines.
פילוחי מדדים פיננסיים ומדדי שוק עבור abeonatherapeutics.com (ABEO)

This indicator measures the gap between current market value and intrinsic revenue generation potential, identifying phases of asset undervaluation. For Abeona Therapeutics (ABEO), which is finalizing the market launch of its gene therapy, the projected future sales metric reflects an expected transition to high-margin cash flow following FDA approval, signaling the business's readiness for rapid scaling.